Valencia-Sola, L.; Becerra-Bolaños, Á.; Mateo-Ferragut, M.; Muiño-Palomar, V.; Ojeda-Betancor, N.; Rodríguez-Pérez, A.
Cytoreductive Surgery (CS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Postoperative Evolution, Adverse Outcomes and Perioperative Risk Factors. Healthcare 2025, 13, 808.
https://doi.org/10.3390/healthcare13070808
AMA Style
Valencia-Sola L, Becerra-Bolaños Á, Mateo-Ferragut M, Muiño-Palomar V, Ojeda-Betancor N, Rodríguez-Pérez A.
Cytoreductive Surgery (CS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Postoperative Evolution, Adverse Outcomes and Perioperative Risk Factors. Healthcare. 2025; 13(7):808.
https://doi.org/10.3390/healthcare13070808
Chicago/Turabian Style
Valencia-Sola, Lucía, Ángel Becerra-Bolaños, María Mateo-Ferragut, Virginia Muiño-Palomar, Nazario Ojeda-Betancor, and Aurelio Rodríguez-Pérez.
2025. "Cytoreductive Surgery (CS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Postoperative Evolution, Adverse Outcomes and Perioperative Risk Factors" Healthcare 13, no. 7: 808.
https://doi.org/10.3390/healthcare13070808
APA Style
Valencia-Sola, L., Becerra-Bolaños, Á., Mateo-Ferragut, M., Muiño-Palomar, V., Ojeda-Betancor, N., & Rodríguez-Pérez, A.
(2025). Cytoreductive Surgery (CS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Postoperative Evolution, Adverse Outcomes and Perioperative Risk Factors. Healthcare, 13(7), 808.
https://doi.org/10.3390/healthcare13070808
